Dividend kings are companies with 50 or more consecutive years of dividend increases. It is the most demanding list in income investing: half a century of uninterrupted raises spanning the oil crisis, 1980s inflation, the dot-com bust, 2008 and a pandemic.
Only a few dozen companies have achieved it — Procter & Gamble, Coca-Cola, Johnson & Johnson and Colgate-Palmolive are the classic names — and the list barely changes: getting in takes 50 years, getting out takes a single cut.
It is not statistical luck. Surviving 50 years of increases requires a business with three simultaneous properties:
| Kings | Aristocrats | |
|---|---|---|
| Years of increases | 50+ | 25+ |
| Index requirement | None | S&P 500 |
| Approximate number | A few dozen | 60–70 |
| Typical profile | Extreme maturity, moderate yield | More sector variety |
The crown has a cost: these businesses are so mature that dividend growth is usually modest (3–6% a year). You are buying extreme reliability, not acceleration.
They work as the defensive core of an income portfolio: their probability of a cut is the lowest in the market. Their limits are equally clear — concentration in consumer staples and healthcare, sensitivity to high interest rates (they compete with bonds) and the risk of paying an excessive premium for the label. An expensive king is still a bad purchase.
The list hovers around a few dozen companies and varies slightly each year depending on the compiler's criteria (there is no single official index). Almost all are American, reflecting the quarterly growing-dividend culture.
Under the strict 50-consecutive-years criterion, almost none: Europe's historical culture favoured dividends tied to each year's profit. Equivalent European lists use looser criteria.
More reliable, not necessarily a better investment: the average aristocrat offers somewhat more growth in exchange for less track record. Combining both profiles is the classic base of a dividend-growth portfolio.